Esther W Chan, PhD

Professor
Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

Poster(s):

• (026) Real-world effectiveness of oral novel hormonal agents in patients with advanced prostate cancer: a head-to-head comparison using longitudinal, territory-wide electronic medical records
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (087) Association of Substance Use Disorder and Risk of COVID-19-related Outcomes Among Adults in Hong Kong
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (124) Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (155) Comparative effectiveness and prescribing trends of modified-release versus immediate-release indapamide in patients with hypertension: a cohort study in the UK
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (182) Oral anticoagulant prescription trends and adherence among patients with atrial fibrillation and mitral stenosis in Hong Kong
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (342) Effectiveness of BNT162b2 and CoronaVac in individuals with multimorbidity: a territory-wide case-control study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (356) The Persistence in Risk and Effect Of COVID-19 Vaccination on Long-Term Health Consequences One Year After SARS-Cov-2 Infection: A Territory-Wide Cohort Study in Hong Kong
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST